Grant: Discovery Grants Program - Individual
University of British Columbia
$35,000.00
Application and Development of New Radical Synthetic Methods
EF 2019-20
Résumé
This proposal focuses on the development of new technologies for the synthesis of molecules that are of interest to the pharmaceutical and agrochemical industries. A key goal is the development of new methods for fluorine incorporation into medicinal agents. While not common in natural organisms, fluorine is a valuable component of many bioactive molecules. Currently, over 20% of the top selling pharmaceutical agents contain fluorine. While fluorine is medicinally useful, it is often difficult to incorporate into molecules. The first and second portions of this proposal focus on new technologies for the synthesis of particularly challenging fluorinated motifs using organic free radicals. We will access the key radical intermediates using several different methods, including UV light. We will also investigate new technology using more environmentally-friendly and lower-energy visible light in combination with photoredox catalysis. *** A second important application of fluorine is its medicinal use in positron emission tomography (PET). The 18F isotope is PET-active and is currently utilized in medicinal agents for a wide range of medicinal applications, including tumor imaging. There are a several technical challenges associated with using 18F: it has a short half-life (2 hours) and fluorine is challenging to incorporate into medicinal agents. New technology that can quickly add 18F to pharmaceuticals would, therefore, be of high impact to the medical community. We will utilize mechanistic insight recently obtained in my laboratory for the development of new 18F-incorporation technology exploiting both radical and ionic (fluoride) mechanisms.*** The third portion of the research proposal focuses on new methods for the rapid synthesis of bioactive natural products. Natural products are of vital importance to the pharmaceutical industry as they often serve as the basis of new medicinal agents. To wit, nearly 50% of all anti-cancer compounds currently on the market either are natural products or are based upon them. Synthetically, one of the challenges in natural product synthesis is their rapid assembly to enable the synthesis of analogs. We plan to develop new radical and pericyclic methodologies for the synthesis of bioactive macrolides that will enable multiple bond forming processes in a single reaction.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2015-05856
Name nom
Sammis, Glenn
Department département
Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2015
Award amount
35000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Installment
inst:5 - 5
Partie
5
Nb partie
5
Application title
Application and Development of New Radical Synthetic Methods
Keyword
NSERC
Application summary
This proposal focuses on the development of new technologies for the synthesis of molecules that are of interest to the pharmaceutical and agrochemical industries. A key goal is the development of new methods for fluorine incorporation into medicinal agents. While not common in natural organisms, fluorine is a valuable component of many bioactive molecules. Currently, over 20% of the top selling pharmaceutical agents contain fluorine. While fluorine is medicinally useful, it is often difficult to incorporate into molecules. The first and second portions of this proposal focus on new technologies for the synthesis of particularly challenging fluorinated motifs using organic free radicals. We will access the key radical intermediates using several different methods, including UV light. We will also investigate new technology using more environmentally-friendly and lower-energy visible light in combination with photoredox catalysis. *** A second important application of fluorine is its medicinal use in positron emission tomography (PET). The 18F isotope is PET-active and is currently utilized in medicinal agents for a wide range of medicinal applications, including tumor imaging. There are a several technical challenges associated with using 18F: it has a short half-life (2 hours) and fluorine is challenging to incorporate into medicinal agents. New technology that can quickly add 18F to pharmaceuticals would, therefore, be of high impact to the medical community. We will utilize mechanistic insight recently obtained in my laboratory for the development of new 18F-incorporation technology exploiting both radical and ionic (fluoride) mechanisms.*** The third portion of the research proposal focuses on new methods for the rapid synthesis of bioactive natural products. Natural products are of vital importance to the pharmaceutical industry as they often serve as the basis of new medicinal agents. To wit, nearly 50% of all anti-cancer compounds currently on the market either are natural products or are based upon them. Synthetically, one of the challenges in natural product synthesis is their rapid assembly to enable the synthesis of analogs. We plan to develop new radical and pericyclic methodologies for the synthesis of bioactive macrolides that will enable multiple bond forming processes in a single reaction.